NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 195 filers reported holding NEVRO CORP in Q3 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,768 | +75.6% | 144 | +132.3% | 0.00% | – |
| Q2 2023 | $1,576 | -57.3% | 62 | -39.2% | 0.00% | – |
| Q1 2023 | $3,687 | +158.6% | 102 | +183.3% | 0.00% | – |
| Q4 2022 | $1,426 | -89.0% | 36 | -86.8% | 0.00% | – |
| Q3 2022 | $13,000 | +225.0% | 272 | +235.8% | 0.00% | – |
| Q2 2022 | $4,000 | -55.6% | 81 | -35.7% | 0.00% | – |
| Q1 2022 | $9,000 | -77.5% | 126 | -74.7% | 0.00% | -100.0% |
| Q4 2021 | $40,000 | +3900.0% | 499 | +7028.6% | 0.00% | – |
| Q3 2021 | $1,000 | -50.0% | 7 | -36.4% | 0.00% | – |
| Q2 2021 | $2,000 | +100.0% | 11 | +120.0% | 0.00% | – |
| Q3 2020 | $1,000 | -87.5% | 5 | -93.2% | 0.00% | -100.0% |
| Q3 2016 | $8,000 | – | 74 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |